nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00415	0.00415	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00415	0.00415	CcSEcCtD
Meropenem—Neuropathy peripheral—Simvastatin—atherosclerosis	0.0041	0.0041	CcSEcCtD
Meropenem—Jaundice—Simvastatin—atherosclerosis	0.00408	0.00408	CcSEcCtD
Meropenem—Flatulence—Rosuvastatin—atherosclerosis	0.00406	0.00406	CcSEcCtD
Meropenem—Hepatitis—Lovastatin—atherosclerosis	0.00401	0.00401	CcSEcCtD
Meropenem—Dysuria—Pravastatin—atherosclerosis	0.00397	0.00397	CcSEcCtD
Meropenem—Hepatitis—Ezetimibe—atherosclerosis	0.00394	0.00394	CcSEcCtD
Meropenem—Pharyngitis—Ezetimibe—atherosclerosis	0.00391	0.00391	CcSEcCtD
Meropenem—Oedema peripheral—Ezetimibe—atherosclerosis	0.00388	0.00388	CcSEcCtD
Meropenem—Erythema multiforme—Lovastatin—atherosclerosis	0.0038	0.0038	CcSEcCtD
Meropenem—Angioedema—Rosuvastatin—atherosclerosis	0.00377	0.00377	CcSEcCtD
Meropenem—Hepatitis—Simvastatin—atherosclerosis	0.00375	0.00375	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00375	0.00375	CcSEcCtD
Meropenem—Jaundice—Niacin—atherosclerosis	0.00374	0.00374	CcSEcCtD
Meropenem—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00373	0.00373	CcSEcCtD
Meropenem—Erythema multiforme—Ezetimibe—atherosclerosis	0.00372	0.00372	CcSEcCtD
Meropenem—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00371	0.00371	CcSEcCtD
Meropenem—Myocardial infarction—Pravastatin—atherosclerosis	0.00371	0.00371	CcSEcCtD
Meropenem—Jaundice—Pravastatin—atherosclerosis	0.00369	0.00369	CcSEcCtD
Meropenem—Sweating—Niacin—atherosclerosis	0.00368	0.00368	CcSEcCtD
Meropenem—Chills—Lovastatin—atherosclerosis	0.0036	0.0036	CcSEcCtD
Meropenem—Cough—Rosuvastatin—atherosclerosis	0.0036	0.0036	CcSEcCtD
Meropenem—Immune system disorder—Ezetimibe—atherosclerosis	0.00356	0.00356	CcSEcCtD
Meropenem—Erythema multiforme—Simvastatin—atherosclerosis	0.00355	0.00355	CcSEcCtD
Meropenem—Haemoglobin—Niacin—atherosclerosis	0.00347	0.00347	CcSEcCtD
Meropenem—Haemorrhage—Niacin—atherosclerosis	0.00345	0.00345	CcSEcCtD
Meropenem—Hepatitis—Niacin—atherosclerosis	0.00345	0.00345	CcSEcCtD
Meropenem—Flatulence—Lovastatin—atherosclerosis	0.00344	0.00344	CcSEcCtD
Meropenem—Erythema—Ezetimibe—atherosclerosis	0.00343	0.00343	CcSEcCtD
Meropenem—Dysgeusia—Lovastatin—atherosclerosis	0.00342	0.00342	CcSEcCtD
Meropenem—Oedema peripheral—Niacin—atherosclerosis	0.0034	0.0034	CcSEcCtD
Meropenem—Hepatitis—Pravastatin—atherosclerosis	0.00339	0.00339	CcSEcCtD
Meropenem—Confusional state—Rosuvastatin—atherosclerosis	0.00339	0.00339	CcSEcCtD
Meropenem—Back pain—Lovastatin—atherosclerosis	0.00338	0.00338	CcSEcCtD
Meropenem—Flatulence—Ezetimibe—atherosclerosis	0.00338	0.00338	CcSEcCtD
Meropenem—Pharyngitis—Pravastatin—atherosclerosis	0.00337	0.00337	CcSEcCtD
Meropenem—Chills—Simvastatin—atherosclerosis	0.00337	0.00337	CcSEcCtD
Meropenem—Infection—Rosuvastatin—atherosclerosis	0.00334	0.00334	CcSEcCtD
Meropenem—Back pain—Ezetimibe—atherosclerosis	0.00332	0.00332	CcSEcCtD
Meropenem—Nervous system disorder—Rosuvastatin—atherosclerosis	0.0033	0.0033	CcSEcCtD
Meropenem—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0033	0.0033	CcSEcCtD
Meropenem—Erythema—Simvastatin—atherosclerosis	0.00327	0.00327	CcSEcCtD
Meropenem—Flatulence—Simvastatin—atherosclerosis	0.00322	0.00322	CcSEcCtD
Meropenem—Erythema multiforme—Pravastatin—atherosclerosis	0.00321	0.00321	CcSEcCtD
Meropenem—Dysgeusia—Simvastatin—atherosclerosis	0.0032	0.0032	CcSEcCtD
Meropenem—Angioedema—Lovastatin—atherosclerosis	0.00319	0.00319	CcSEcCtD
Meropenem—Anaemia—Ezetimibe—atherosclerosis	0.00317	0.00317	CcSEcCtD
Meropenem—Malaise—Lovastatin—atherosclerosis	0.00315	0.00315	CcSEcCtD
Meropenem—Angioedema—Ezetimibe—atherosclerosis	0.00313	0.00313	CcSEcCtD
Meropenem—Leukopenia—Lovastatin—atherosclerosis	0.00313	0.00313	CcSEcCtD
Meropenem—Chills—Niacin—atherosclerosis	0.00309	0.00309	CcSEcCtD
Meropenem—Malaise—Ezetimibe—atherosclerosis	0.00309	0.00309	CcSEcCtD
Meropenem—Chills—Pravastatin—atherosclerosis	0.00305	0.00305	CcSEcCtD
Meropenem—Insomnia—Rosuvastatin—atherosclerosis	0.00304	0.00304	CcSEcCtD
Meropenem—Paraesthesia—Rosuvastatin—atherosclerosis	0.00302	0.00302	CcSEcCtD
Meropenem—Anaemia—Simvastatin—atherosclerosis	0.00302	0.00302	CcSEcCtD
Meropenem—Erythema—Niacin—atherosclerosis	0.003	0.003	CcSEcCtD
Meropenem—Cough—Ezetimibe—atherosclerosis	0.00299	0.00299	CcSEcCtD
Meropenem—Angioedema—Simvastatin—atherosclerosis	0.00299	0.00299	CcSEcCtD
Meropenem—Chest pain—Lovastatin—atherosclerosis	0.00298	0.00298	CcSEcCtD
Meropenem—Anxiety—Lovastatin—atherosclerosis	0.00296	0.00296	CcSEcCtD
Meropenem—Dyspepsia—Rosuvastatin—atherosclerosis	0.00296	0.00296	CcSEcCtD
Meropenem—Hypertension—Ezetimibe—atherosclerosis	0.00296	0.00296	CcSEcCtD
Meropenem—Flatulence—Niacin—atherosclerosis	0.00296	0.00296	CcSEcCtD
Meropenem—Malaise—Simvastatin—atherosclerosis	0.00295	0.00295	CcSEcCtD
Meropenem—Tension—Niacin—atherosclerosis	0.00295	0.00295	CcSEcCtD
Meropenem—Leukopenia—Simvastatin—atherosclerosis	0.00293	0.00293	CcSEcCtD
Meropenem—Chest pain—Ezetimibe—atherosclerosis	0.00292	0.00292	CcSEcCtD
Meropenem—Nervousness—Niacin—atherosclerosis	0.00292	0.00292	CcSEcCtD
Meropenem—Flatulence—Pravastatin—atherosclerosis	0.00291	0.00291	CcSEcCtD
Meropenem—Tension—Pravastatin—atherosclerosis	0.0029	0.0029	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0029	0.0029	CcSEcCtD
Meropenem—Dysgeusia—Pravastatin—atherosclerosis	0.00289	0.00289	CcSEcCtD
Meropenem—Constipation—Rosuvastatin—atherosclerosis	0.00288	0.00288	CcSEcCtD
Meropenem—Pain—Rosuvastatin—atherosclerosis	0.00288	0.00288	CcSEcCtD
Meropenem—Confusional state—Lovastatin—atherosclerosis	0.00288	0.00288	CcSEcCtD
Meropenem—Nervousness—Pravastatin—atherosclerosis	0.00287	0.00287	CcSEcCtD
Meropenem—Anaphylactic shock—Lovastatin—atherosclerosis	0.00285	0.00285	CcSEcCtD
Meropenem—Infection—Lovastatin—atherosclerosis	0.00283	0.00283	CcSEcCtD
Meropenem—Confusional state—Ezetimibe—atherosclerosis	0.00282	0.00282	CcSEcCtD
Meropenem—Anaphylactic shock—Ezetimibe—atherosclerosis	0.0028	0.0028	CcSEcCtD
Meropenem—Thrombocytopenia—Lovastatin—atherosclerosis	0.00279	0.00279	CcSEcCtD
Meropenem—Chest pain—Simvastatin—atherosclerosis	0.00278	0.00278	CcSEcCtD
Meropenem—Infection—Ezetimibe—atherosclerosis	0.00278	0.00278	CcSEcCtD
Meropenem—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00277	0.00277	CcSEcCtD
Meropenem—Anxiety—Simvastatin—atherosclerosis	0.00277	0.00277	CcSEcCtD
Meropenem—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00275	0.00275	CcSEcCtD
Meropenem—Nervous system disorder—Ezetimibe—atherosclerosis	0.00274	0.00274	CcSEcCtD
Meropenem—Angioedema—Niacin—atherosclerosis	0.00274	0.00274	CcSEcCtD
Meropenem—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00274	0.00274	CcSEcCtD
Meropenem—Anaemia—Pravastatin—atherosclerosis	0.00273	0.00273	CcSEcCtD
Meropenem—Anorexia—Lovastatin—atherosclerosis	0.00272	0.00272	CcSEcCtD
Meropenem—Skin disorder—Ezetimibe—atherosclerosis	0.00272	0.00272	CcSEcCtD
Meropenem—Angioedema—Pravastatin—atherosclerosis	0.0027	0.0027	CcSEcCtD
Meropenem—Syncope—Niacin—atherosclerosis	0.00269	0.00269	CcSEcCtD
Meropenem—Confusional state—Simvastatin—atherosclerosis	0.00269	0.00269	CcSEcCtD
Meropenem—Leukopenia—Niacin—atherosclerosis	0.00269	0.00269	CcSEcCtD
Meropenem—Urticaria—Rosuvastatin—atherosclerosis	0.00267	0.00267	CcSEcCtD
Meropenem—Anaphylactic shock—Simvastatin—atherosclerosis	0.00267	0.00267	CcSEcCtD
Meropenem—Oedema—Simvastatin—atherosclerosis	0.00267	0.00267	CcSEcCtD
Meropenem—Malaise—Pravastatin—atherosclerosis	0.00266	0.00266	CcSEcCtD
Meropenem—Abdominal pain—Rosuvastatin—atherosclerosis	0.00266	0.00266	CcSEcCtD
Meropenem—Infection—Simvastatin—atherosclerosis	0.00265	0.00265	CcSEcCtD
Meropenem—Leukopenia—Pravastatin—atherosclerosis	0.00265	0.00265	CcSEcCtD
Meropenem—Loss of consciousness—Niacin—atherosclerosis	0.00264	0.00264	CcSEcCtD
Meropenem—Cough—Niacin—atherosclerosis	0.00262	0.00262	CcSEcCtD
Meropenem—Thrombocytopenia—Simvastatin—atherosclerosis	0.00261	0.00261	CcSEcCtD
Meropenem—Insomnia—Lovastatin—atherosclerosis	0.00258	0.00258	CcSEcCtD
Meropenem—Cough—Pravastatin—atherosclerosis	0.00258	0.00258	CcSEcCtD
Meropenem—Paraesthesia—Lovastatin—atherosclerosis	0.00256	0.00256	CcSEcCtD
Meropenem—Hypertension—Pravastatin—atherosclerosis	0.00255	0.00255	CcSEcCtD
Meropenem—Anorexia—Simvastatin—atherosclerosis	0.00254	0.00254	CcSEcCtD
Meropenem—Dyspnoea—Lovastatin—atherosclerosis	0.00254	0.00254	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00254	0.00254	CcSEcCtD
Meropenem—Insomnia—Ezetimibe—atherosclerosis	0.00253	0.00253	CcSEcCtD
Meropenem—Chest pain—Pravastatin—atherosclerosis	0.00252	0.00252	CcSEcCtD
Meropenem—Paraesthesia—Ezetimibe—atherosclerosis	0.00251	0.00251	CcSEcCtD
Meropenem—Dyspepsia—Lovastatin—atherosclerosis	0.00251	0.00251	CcSEcCtD
Meropenem—Anxiety—Pravastatin—atherosclerosis	0.00251	0.00251	CcSEcCtD
Meropenem—Dyspnoea—Ezetimibe—atherosclerosis	0.00249	0.00249	CcSEcCtD
Meropenem—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00248	0.00248	CcSEcCtD
Meropenem—Decreased appetite—Lovastatin—atherosclerosis	0.00248	0.00248	CcSEcCtD
Meropenem—Dyspepsia—Ezetimibe—atherosclerosis	0.00246	0.00246	CcSEcCtD
Meropenem—Anaphylactic shock—Niacin—atherosclerosis	0.00245	0.00245	CcSEcCtD
Meropenem—Oedema—Niacin—atherosclerosis	0.00245	0.00245	CcSEcCtD
Meropenem—Pain—Lovastatin—atherosclerosis	0.00244	0.00244	CcSEcCtD
Meropenem—Constipation—Lovastatin—atherosclerosis	0.00244	0.00244	CcSEcCtD
Meropenem—Confusional state—Pravastatin—atherosclerosis	0.00243	0.00243	CcSEcCtD
Meropenem—Decreased appetite—Ezetimibe—atherosclerosis	0.00243	0.00243	CcSEcCtD
Meropenem—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00242	0.00242	CcSEcCtD
Meropenem—Asthenia—Rosuvastatin—atherosclerosis	0.00241	0.00241	CcSEcCtD
Meropenem—Insomnia—Simvastatin—atherosclerosis	0.00241	0.00241	CcSEcCtD
Meropenem—Oedema—Pravastatin—atherosclerosis	0.00241	0.00241	CcSEcCtD
Meropenem—Anaphylactic shock—Pravastatin—atherosclerosis	0.00241	0.00241	CcSEcCtD
Meropenem—Shock—Niacin—atherosclerosis	0.00241	0.00241	CcSEcCtD
Meropenem—Infection—Pravastatin—atherosclerosis	0.0024	0.0024	CcSEcCtD
Meropenem—Paraesthesia—Simvastatin—atherosclerosis	0.0024	0.0024	CcSEcCtD
Meropenem—Pain—Ezetimibe—atherosclerosis	0.00239	0.00239	CcSEcCtD
Meropenem—Constipation—Ezetimibe—atherosclerosis	0.00239	0.00239	CcSEcCtD
Meropenem—Tachycardia—Niacin—atherosclerosis	0.00239	0.00239	CcSEcCtD
Meropenem—Pruritus—Rosuvastatin—atherosclerosis	0.00238	0.00238	CcSEcCtD
Meropenem—Skin disorder—Niacin—atherosclerosis	0.00238	0.00238	CcSEcCtD
Meropenem—Dyspnoea—Simvastatin—atherosclerosis	0.00238	0.00238	CcSEcCtD
Meropenem—Hyperhidrosis—Niacin—atherosclerosis	0.00237	0.00237	CcSEcCtD
Meropenem—Thrombocytopenia—Pravastatin—atherosclerosis	0.00236	0.00236	CcSEcCtD
Meropenem—Feeling abnormal—Lovastatin—atherosclerosis	0.00235	0.00235	CcSEcCtD
Meropenem—Dyspepsia—Simvastatin—atherosclerosis	0.00235	0.00235	CcSEcCtD
Meropenem—Anorexia—Niacin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Meropenem—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Meropenem—Hyperhidrosis—Pravastatin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Meropenem—Decreased appetite—Simvastatin—atherosclerosis	0.00232	0.00232	CcSEcCtD
Meropenem—Feeling abnormal—Ezetimibe—atherosclerosis	0.00231	0.00231	CcSEcCtD
Meropenem—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0023	0.0023	CcSEcCtD
Meropenem—Diarrhoea—Rosuvastatin—atherosclerosis	0.0023	0.0023	CcSEcCtD
Meropenem—Anorexia—Pravastatin—atherosclerosis	0.0023	0.0023	CcSEcCtD
Meropenem—Hypotension—Niacin—atherosclerosis	0.00229	0.00229	CcSEcCtD
Meropenem—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00229	0.00229	CcSEcCtD
Meropenem—Pain—Simvastatin—atherosclerosis	0.00228	0.00228	CcSEcCtD
Meropenem—Constipation—Simvastatin—atherosclerosis	0.00228	0.00228	CcSEcCtD
Meropenem—Urticaria—Lovastatin—atherosclerosis	0.00227	0.00227	CcSEcCtD
Meropenem—Body temperature increased—Lovastatin—atherosclerosis	0.00225	0.00225	CcSEcCtD
Meropenem—Abdominal pain—Lovastatin—atherosclerosis	0.00225	0.00225	CcSEcCtD
Meropenem—Dizziness—Rosuvastatin—atherosclerosis	0.00223	0.00223	CcSEcCtD
Meropenem—Urticaria—Ezetimibe—atherosclerosis	0.00222	0.00222	CcSEcCtD
Meropenem—Insomnia—Niacin—atherosclerosis	0.00222	0.00222	CcSEcCtD
Meropenem—Body temperature increased—Ezetimibe—atherosclerosis	0.00221	0.00221	CcSEcCtD
Meropenem—Abdominal pain—Ezetimibe—atherosclerosis	0.00221	0.00221	CcSEcCtD
Meropenem—Paraesthesia—Niacin—atherosclerosis	0.0022	0.0022	CcSEcCtD
Meropenem—Feeling abnormal—Simvastatin—atherosclerosis	0.0022	0.0022	CcSEcCtD
Meropenem—Dyspnoea—Niacin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Meropenem—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Meropenem—Insomnia—Pravastatin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Meropenem—Somnolence—Niacin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Meropenem—Paraesthesia—Pravastatin—atherosclerosis	0.00217	0.00217	CcSEcCtD
Meropenem—Dyspepsia—Niacin—atherosclerosis	0.00216	0.00216	CcSEcCtD
Meropenem—Dyspnoea—Pravastatin—atherosclerosis	0.00215	0.00215	CcSEcCtD
Meropenem—Decreased appetite—Niacin—atherosclerosis	0.00213	0.00213	CcSEcCtD
Meropenem—Dyspepsia—Pravastatin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Meropenem—Rash—Rosuvastatin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Meropenem—Dermatitis—Rosuvastatin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Meropenem—Urticaria—Simvastatin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Meropenem—Gastrointestinal disorder—Niacin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Meropenem—Abdominal pain—Simvastatin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Meropenem—Body temperature increased—Simvastatin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Meropenem—Headache—Rosuvastatin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Meropenem—Hypersensitivity—Lovastatin—atherosclerosis	0.0021	0.0021	CcSEcCtD
Meropenem—Decreased appetite—Pravastatin—atherosclerosis	0.0021	0.0021	CcSEcCtD
Meropenem—Pain—Niacin—atherosclerosis	0.00209	0.00209	CcSEcCtD
Meropenem—Constipation—Pravastatin—atherosclerosis	0.00206	0.00206	CcSEcCtD
Meropenem—Pain—Pravastatin—atherosclerosis	0.00206	0.00206	CcSEcCtD
Meropenem—Hypersensitivity—Ezetimibe—atherosclerosis	0.00206	0.00206	CcSEcCtD
Meropenem—Asthenia—Lovastatin—atherosclerosis	0.00205	0.00205	CcSEcCtD
Meropenem—Pruritus—Lovastatin—atherosclerosis	0.00202	0.00202	CcSEcCtD
Meropenem—Asthenia—Ezetimibe—atherosclerosis	0.00201	0.00201	CcSEcCtD
Meropenem—Gastrointestinal pain—Niacin—atherosclerosis	0.002	0.002	CcSEcCtD
Meropenem—Nausea—Rosuvastatin—atherosclerosis	0.002	0.002	CcSEcCtD
Meropenem—Feeling abnormal—Pravastatin—atherosclerosis	0.00199	0.00199	CcSEcCtD
Meropenem—Pruritus—Ezetimibe—atherosclerosis	0.00198	0.00198	CcSEcCtD
Meropenem—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00197	0.00197	CcSEcCtD
Meropenem—Hypersensitivity—Simvastatin—atherosclerosis	0.00197	0.00197	CcSEcCtD
Meropenem—Diarrhoea—Lovastatin—atherosclerosis	0.00195	0.00195	CcSEcCtD
Meropenem—Urticaria—Niacin—atherosclerosis	0.00195	0.00195	CcSEcCtD
Meropenem—Abdominal pain—Niacin—atherosclerosis	0.00194	0.00194	CcSEcCtD
Meropenem—Body temperature increased—Niacin—atherosclerosis	0.00194	0.00194	CcSEcCtD
Meropenem—Urticaria—Pravastatin—atherosclerosis	0.00192	0.00192	CcSEcCtD
Meropenem—Asthenia—Simvastatin—atherosclerosis	0.00191	0.00191	CcSEcCtD
Meropenem—Diarrhoea—Ezetimibe—atherosclerosis	0.00191	0.00191	CcSEcCtD
Meropenem—Abdominal pain—Pravastatin—atherosclerosis	0.00191	0.00191	CcSEcCtD
Meropenem—Body temperature increased—Pravastatin—atherosclerosis	0.00191	0.00191	CcSEcCtD
Meropenem—Pruritus—Simvastatin—atherosclerosis	0.00189	0.00189	CcSEcCtD
Meropenem—Dizziness—Lovastatin—atherosclerosis	0.00189	0.00189	CcSEcCtD
Meropenem—Dizziness—Ezetimibe—atherosclerosis	0.00185	0.00185	CcSEcCtD
Meropenem—Diarrhoea—Simvastatin—atherosclerosis	0.00183	0.00183	CcSEcCtD
Meropenem—Vomiting—Lovastatin—atherosclerosis	0.00181	0.00181	CcSEcCtD
Meropenem—Hypersensitivity—Niacin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Meropenem—Rash—Lovastatin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Meropenem—Dermatitis—Lovastatin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Meropenem—Headache—Lovastatin—atherosclerosis	0.00179	0.00179	CcSEcCtD
Meropenem—Vomiting—Ezetimibe—atherosclerosis	0.00178	0.00178	CcSEcCtD
Meropenem—Hypersensitivity—Pravastatin—atherosclerosis	0.00178	0.00178	CcSEcCtD
Meropenem—Dizziness—Simvastatin—atherosclerosis	0.00176	0.00176	CcSEcCtD
Meropenem—Rash—Ezetimibe—atherosclerosis	0.00176	0.00176	CcSEcCtD
Meropenem—Dermatitis—Ezetimibe—atherosclerosis	0.00176	0.00176	CcSEcCtD
Meropenem—Asthenia—Niacin—atherosclerosis	0.00176	0.00176	CcSEcCtD
Meropenem—Headache—Ezetimibe—atherosclerosis	0.00175	0.00175	CcSEcCtD
Meropenem—Pruritus—Niacin—atherosclerosis	0.00173	0.00173	CcSEcCtD
Meropenem—Asthenia—Pravastatin—atherosclerosis	0.00173	0.00173	CcSEcCtD
Meropenem—Pruritus—Pravastatin—atherosclerosis	0.00171	0.00171	CcSEcCtD
Meropenem—Vomiting—Simvastatin—atherosclerosis	0.0017	0.0017	CcSEcCtD
Meropenem—Nausea—Lovastatin—atherosclerosis	0.00169	0.00169	CcSEcCtD
Meropenem—Rash—Simvastatin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Meropenem—Dermatitis—Simvastatin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Meropenem—Diarrhoea—Niacin—atherosclerosis	0.00168	0.00168	CcSEcCtD
Meropenem—Headache—Simvastatin—atherosclerosis	0.00167	0.00167	CcSEcCtD
Meropenem—Nausea—Ezetimibe—atherosclerosis	0.00166	0.00166	CcSEcCtD
Meropenem—Diarrhoea—Pravastatin—atherosclerosis	0.00165	0.00165	CcSEcCtD
Meropenem—Dizziness—Niacin—atherosclerosis	0.00162	0.00162	CcSEcCtD
Meropenem—Dizziness—Pravastatin—atherosclerosis	0.00159	0.00159	CcSEcCtD
Meropenem—Nausea—Simvastatin—atherosclerosis	0.00158	0.00158	CcSEcCtD
Meropenem—Vomiting—Niacin—atherosclerosis	0.00156	0.00156	CcSEcCtD
Meropenem—Rash—Niacin—atherosclerosis	0.00154	0.00154	CcSEcCtD
Meropenem—Dermatitis—Niacin—atherosclerosis	0.00154	0.00154	CcSEcCtD
Meropenem—Headache—Niacin—atherosclerosis	0.00153	0.00153	CcSEcCtD
Meropenem—Vomiting—Pravastatin—atherosclerosis	0.00153	0.00153	CcSEcCtD
Meropenem—Rash—Pravastatin—atherosclerosis	0.00152	0.00152	CcSEcCtD
Meropenem—Dermatitis—Pravastatin—atherosclerosis	0.00152	0.00152	CcSEcCtD
Meropenem—Headache—Pravastatin—atherosclerosis	0.00151	0.00151	CcSEcCtD
Meropenem—Nausea—Niacin—atherosclerosis	0.00145	0.00145	CcSEcCtD
Meropenem—Nausea—Pravastatin—atherosclerosis	0.00143	0.00143	CcSEcCtD
